Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial

NCT03567577 is registered in ClinicalTrials.gov with Apeptico Forschung und Entwicklung GmbH as lead sponsor.

NCT NCT03567577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03567577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS - a Randomised, Placebo-controlled, Double-blind Trial
Lead sponsor
Apeptico Forschung und Entwicklung GmbH
Phase
Phase 2
Overall status
Completed
Start date
May 23, 2018
Completion date
December 27, 2024
Enrollment
92 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

ards